Who is sponsoring NCT05020379?

NCT05020379 is sponsored by Karaman Training and Research Hospital.

What drugs are being tested in NCT05020379?

Interventions in NCT05020379: Perioperative and postoperative multimodal analgesia, ESP Block.

What condition does NCT05020379 study?

NCT05020379 studies Laparoscopic Bariatric Surgery.

Is NCT05020379 still recruiting?

NCT05020379 is currently completed. Last updated 28 October 2022.

Last reviewed 2022-10-28 · How we verify

NCT05020379

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Erector Spinae Plane Block on Bariatric Surgery.

Completed NA Last updated 28 October 2022

What this trial tests

NA trial testing Perioperative and postoperative multimodal analgesia in Laparoscopic Bariatric Surgery in 80 participants. Completed in 27 October 2022.

Timeline

10 September 2021

Primary endpoint
27 September 2022

27 October 2022

Quick facts

Lead sponsor	Karaman Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	10 September 2021
Primary completion	27 September 2022
Estimated completion	27 October 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Perioperative and postoperative multimodal analgesia
ESP Block — full drug profile →

Conditions studied

Laparoscopic Bariatric Surgery — all drugs for Laparoscopic Bariatric Surgery →

Sponsor

Karaman Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Laparoscopic Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The erector spinae plane block (ESPB) is a new technique that is increasingly used in the treatment of acute and chronic pain. Bariatric surgery is a surgical treatment method used in the treatment of morbid obesity and related comorbidities. Providing pain control in obese patients is a topic that remains up-to-date. Poorly controlled early postoperative pain impairs quality of recovery, increases the risk of postoperative pulmonary complications, and is a risk factor for the subsequent development of chronic pain. Therefore, optimizing acute postoperative analgesia is a priority in patients undergoing bariatric surgery. The primary aim of this prospective, randomized study is to evaluate the effect of ESPB on quality of recovery with the QoR-40 questionnaire in patients undergoing elective Laparoscopic Bariatric Surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of the Erector Spinae Plane Block for Quality of Recovery in Bariatric Surgery: a Randomized Controlled Trial.
Toprak H, Başaran B, Toprak ŞS, Et T, et al · · 2023 · cited 14× · PMID 37488349 · DOI 10.1007/s11695-023-06748-3

Verify or expand the search:

Other Karaman Training and Research Hospital trials

Trials by the same sponsor.

NCT07130552 — Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty · NA · recruiting
NCT07102407 — Effect of a Constructivist Educational Program on Preventing Ventilator-Associated Pneumonia in Intensive Care Units · NA · recruiting
NCT06616740 — Effects of Paratracheal Compression and Cricoid Compression on LMA ProSeal Placement · NA · completed
NCT06605937 — The Effect of Postoperative Eustachian Milking Maneuver on Eustachian Tube Dysfunction · completed
NCT06634680 — Effects of Different Parental Involvement on Anxiety and Delirium · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05020379 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karaman Training and Research Hospital
Last refreshed: 28 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05020379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing